The 10% mindset and power of bold ideas | Prof. Dr. Dominik Ruettinger, Global Head R&D oncology, Bayer Pharmaceuticals
A conversation with Dr. Dominik Ruettinger, Global Head R&D oncology, Bayer Pharmaceuticals
A conversation with Dr. Dominik Ruettinger, Global Head R&D oncology, Bayer Pharmaceuticals
Biotech may be global in ambition, but ecosystems thrive when capital arrives and stays.
A conversation with Dr. Uli Stilz, Head of Bio Innovation Hub at Novo Nordisk.
A conversation with Dr. Marina Gerner, journalist and author of The Vagina Business
Explore how to identify entrepreneurial academics in biotech using key metrics like startup leadership, patents, and research grants.
A conversation with Luke Timmerman, award-winning biotech journalist and founder of the Timmerman Report.
This report highlights the leading biotechnology venture capitalists in the Chicagoland area and provides an overview of its biotech investment landscape.
Brazilian VC funding in biotech is on the rise, with approximately 50 firms investing in a diverse range of biotech sectors.
Introduction to the Nucleate Biotech Ecosystem Insights Series.
The human story of biotechnology, and how it will change life as we know it.
Host Sam Kessel Listen Apple Podcasts Spotify Watch YouTube...
Every year our international Nucleate community comes together to connect, learn and celebrate at the annual Alumni Summit. The Summit brings together members of Nucleate leadership and Activator alumni with our dedicated partners and sponsors to reflect on our journey thus far and envision the future of biotech innovation together....
A conversation with Dr. Allyson Berent, CSO, Foundation For Angelman Syndrome Therapeutics (FAST)
A conversation with Joe Horsman, Madrona VC
A conversation with Armon Sharei, Founder & CEO at Portal
A deep dive into Denmark’s pharma-driven biotech boom and Norway’s eco-tech pivot, featuring insights from Nordic industry leaders in Nucleate’s Hidden Layers × Inside Global Life Sciences series.